ReposiTrak, Inc. (TRAK)

ReposiTrak, Inc. operates as a Software-as-a-Service company providing a business-to-business e-commerce, compliance, traceability, and supply chain management platform. The platform enables retailers, wholesalers, distributors, and their suppliers to manage supply chain programs, including out-of-stock management and scan-based trading; manage compliance documents and data and support compliance with traceability requirements; and improve product ordering and forecasting to increase supply chain efficiency and manage risk. The company's principal customers are multi-store retail chains, wholesalers, distributors, and their suppliers, with the bulk of customers in the U.S. consumer retail sector for food, convenience stores, and general merchandise. The U.S. consumer retail sector faces pressure from increased competitive pressures from online retailers, increased regulatory and tort risks for food retailers due to the Food Safety Modernization Act, and consumer pressure to increase product diversity, particularly smaller, localized vendors.

The company competes with various software vendors, developers and integrators, B2B exchanges, consulting firms, focused solution providers, and business intelligence technology platforms. Although competitors are often considerably larger with larger sales forces and marketing budgets, the company believes its deep industry knowledge, breadth and depth of offerings, and long-standing relationships with key industry, wholesaler, and other trade groups and associations provide a competitive advantage. The company has been awarded nine U.S. patents, and its patent portfolio has been transferred to an unrelated third party, with the company retaining the right to use the licensed patents in connection with its business.

The company generates revenue from five sources: subscription fees, transaction-based fees, professional services fees, license fees, and hosting and maintenance fees. A significant portion of revenue is generated from its Compliance and Supply Chain Food Safety solutions, with a growing portion derived from its newest Traceability solution. The company employs a hub and spoke business model, typically engaged by retailers and wholesalers (Hubs), which in turn require their suppliers (Spokes) to utilize the company's services. Subscription fees can be based on a negotiated flat fee per supplier or a volumetric metric such as the number of stores or the volume of economic activity between a retailer and its suppliers.

The ReposiTrak Compliance Management solutions help customers vet suppliers and reduce potential regulatory, legal, and criminal risk from supply chain partners by ensuring suppliers are compliant with food safety regulations such as the Food Safety Modernization Act of 2011. The ReposiTrak Traceability Network helps customers comply with federal regulatory requirements of traceability, designed to provide a scalable, cost-effective approach to capturing and sharing key data elements required by Section 204(d) of FSMA as designated products move through the supply chain at each critical tracking event, including tracking from farm to shelf. The ReposiTrak Supply Chain Solutions help customers manage interactions with suppliers more efficiently, providing greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, enhancing revenue while lowering working capital, labor costs, and reducing waste.

The company has developed proprietary, patent-pending technologies addressing large-scale traceability data management, focusing on automated detection and correction of errors in supply chain traceability data and generation of compliant traceability records without reliance on case-level scanning or probabilistic methods. The first patent-pending technology uses advanced algorithms and machine learning to identify inconsistencies, omissions, and inaccuracies within traceability datasets and automatically correct such errors in real time. The second patent-pending technology generates end-to-end traceability records across distribution environments without requiring physical scanning of individual cases, leveraging system-level data integration and validation techniques to create compliant Key Data Element records at each Critical Tracking Event. The company also has two professional services groups: the Business Analytics Group offering business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, and the Professional Services Group providing consulting services to ensure solutions are seamlessly integrated into customers' business processes.

During fiscal 2026, the company increased its quarterly cash dividend rate to $0.02 per share ($0.08 annually), beginning with the dividend payable to shareholders of record as of September 30, 2025. On June 18, 2026, the Board of Directors declared a quarterly cash dividend of $0.02 per share, payable to shareholders of record on June 30, 2026, which was paid on or about August 14, 2026, representing an annual dividend yield of approximately 0.88% based on closing prices on June 30, 2026. The company entered into a financing arrangement with SPAR Marketing Force, Inc. providing up to $4.0 million of funding, of which $3.0 million has been advanced, with interest income at 8.0%. On May 29, 2026, the company elected to receive payment of an outstanding balance owed under an amendment to a Services Agreement with SPAR Group, Inc. in shares of Client Stock, resulting in the issuance of 3,190,569 shares at a deemed value of $0.728710119 per share, in consideration of the payment of $2,325,000. On July 1, 2026, the company entered into Stock Purchase Agreements to be issued an aggregate of 4,709,837 shares of SPAR common stock for aggregate contingent consideration of approximately $3.3 million, including a previously paid non-refundable deposit of $100,000, $139,883 to be paid for shares held by William Bartels, $485,118 to be paid for shares held by WHB, and the issuance of an unsecured promissory note in the principal amount of $2,571,885 bearing interest at 6.0% per annum and maturing on July 1, 2030. Since inception of the preferred stock redemption program, the company has redeemed and retired an aggregate of 676,912 shares of Series B Preferred Stock and Series B-1 Preferred Stock at a redemption price of $10.70 per share, for total consideration of approximately $7.2 million, with approximately $1.7 million of Preferred Stock remaining outstanding and subject to redemption as of June 30, 2026.

For the fiscal year ended June 30, 2026, the company generated revenue of $23,287,319, compared with $22,606,066 for the fiscal year ended June 30, 2025, representing an increase of approximately 3%. Net income was $7,569,487 for the year ended June 30, 2026, compared to net income of $6,978,127 for the year ended June 30, 2025. Cost of services and product support was $3,306,855, or 14% of total revenue, for fiscal 2026, compared with $3,681,330, or 16% of total revenue, for fiscal 2025, a decrease of approximately 10%. Sales and marketing expense was $5,751,151, or 25% of total revenue, for fiscal 2026, compared with $5,843,272, or 26% of total revenue, for fiscal 2025, a decrease of approximately 2%. General and administrative expense was $5,738,314, or 25% of total revenue, for fiscal 2026, compared with $5,602,807, or 25% of total revenue, for fiscal 2025, an increase of approximately 2%. Depreciation and amortization expense was $647,637 for fiscal 2026, compared with $1,251,514 for fiscal 2025, a decrease of 48%. Net other income was $1,676,124 for fiscal 2026, compared with $1,426,834 for fiscal 2025, an increase of $249,290, or approximately 17%. Preferred dividends were $167,804 for fiscal 2026, compared with $360,306 for fiscal 2025, a decrease of approximately 53%.

The company's growth is driven by increased regulatory requirements, food safety and traceability initiatives, and greater demand for transparency throughout the food supply chain. The FDA extended the compliance deadline for FSMA 204 by 30 months to July 20, 2028, but adoption of traceability solutions continues to accelerate due to commercial and competitive pressures. Several major retailers have announced traceability requirements that exceed the scope of FSMA 204, including requirements for additional data elements, application across all food categories, and implementation timelines preceding FDA enforcement. The company has developed the ReposiTrak Traceability Network, a scalable, cloud-based solution designed to facilitate compliant traceability through low-cost, rapid deployment across supplier, distributor, and retailer networks, connecting thousands of supply chain participants. The company's patent-pending technologies are integral to its traceability platform and are designed to enhance scalability, reduce implementation complexity, and differentiate the company's offering in a rapidly evolving regulatory and commercial environment.

The company's investment in and commercial relationship with SPAR Group, Inc. represents a significant growth vector. As of June 30, 2026, the company beneficially owned approximately 14.8% of SPAR's outstanding common stock, and on July 1, 2026, acquired an additional 4,709,837 shares, increasing beneficial ownership to approximately 31%. The company provides services to SPAR relating to product development and improvements to certain business and operational processes. The company entered into these transactions based on its expectation that the investment and commercial relationship with SPAR could generate a positive return and contribute to the growth of its business over time. The company is evaluating whether it has the ability to exercise significant influence over SPAR and whether the investment should be accounted for under the equity method of accounting, which could materially affect the manner in which SPAR's operating performance and the investment are reflected in the financial statements.

The company's cost of services and product support decreased by approximately 10% in fiscal 2026, primarily attributable to the capitalization of certain qualifying software development costs that otherwise would have been recognized as expense during the period, partially offset by increased cybersecurity costs and higher offshore development costs associated with the Traceability initiative. Sales and marketing expense decreased by approximately 2%, primarily due to lower personnel costs resulting from a reduction in marketing staff and lower trade show expenses, while the company continued to utilize artificial intelligence and other technology-enabled tools to enhance the efficiency and targeting of its sales and marketing activities. General and administrative expense increased by approximately 2%, primarily due to higher personnel-related costs, including stock-based compensation and employee benefit costs, as well as increased liability insurance premiums, bad debt expense, and travel-related costs.

The company plans to continue expanding its offshore workforce to augment its analytics services offerings, expand its professional services, and provide additional programming resources. As of June 30, 2026, the company employed a total of 67 employees, of whom 22 are located overseas. The company serves its customers from a third-party data center hosting facility that is SSAE No. 16 – SOC2 certified, secured by around-the-clock guards, biometric screening, and escort-controlled access, and supported by multiple on-site backup generators. The production environment and all customer data is replicated in near real-time in a separate facility physically located in a different region of the U.S.

The company's capital allocation priorities include quarterly cash dividends, preferred stock redemptions, and share repurchases. The company has paid quarterly cash dividends since fiscal 2023, and in June 2025, the Board of Directors approved an increase in the quarterly cash dividend to $0.02 per share, or $0.08 per share on an annualized basis. The company currently intends to redeem the remaining outstanding Preferred Stock on or before December 31, 2026, subject to the availability of sufficient cash and other applicable considerations. Under the Share Repurchase Program, the Board of Directors has approved a total of $21.0 million for repurchase, and as of June 30, 2026, $5,993,636 remains available to repurchase. Since inception of the Share Repurchase Program through June 30, 2026, 2,275,288 shares of Common Stock have been repurchased at an average purchase price of $6.60.

The company faces the risk that a delay in the deadline for compliance with FSMA 204 may slow the adoption of its technology as a compliance tool, negatively affecting revenue. The FDA extended the compliance deadline for FSMA 204 by 30 months to July 20, 2028, and if the FDA delays the deadline further and the industry or customers likewise delay information technology spending, customers' ability or willingness to purchase the company's enterprise cloud computing services could be adversely affected. Weakened global economic conditions, including inflationary fluctuations, economic downturns, and volatile business environments, could affect the rate of information technology spending and adversely affect customers' ability or willingness to purchase services, delay purchasing decisions, reduce the value or duration of subscription contracts, or affect renewal rates. Geopolitical conflicts could potentially affect sales and disrupt operations, and the extent of impact depends on future developments that are highly uncertain and cannot be predicted with confidence.

The company's investment in SPAR Group, Inc. and its obligations under the Note issued in connection with a portion of the investment may not generate the returns or benefits anticipated and expose the company to additional risks. The investment is subject to risks associated with an equity investment in a publicly traded company, including fluctuations in market price and liquidity of SPAR's common stock and risks relating to SPAR's business, financial condition, and results of operations. The company does not control SPAR or its board of directors or management, and SPAR may make strategic, operational, financing, or capital allocation decisions with which the company disagrees or that adversely affect the value of the investment. The company's obligation to make principal and interest payments under the Note is independent of the performance or value of the investment in SPAR, and required payments will reduce cash otherwise available for operations, investments, acquisitions, dividends, share repurchases, or other corporate purposes.

Management's message emphasizes the company's position as a SaaS company operating a B2B e-commerce, compliance, traceability, and supply chain management platform, with a focus on recurring subscription-based software services while placing less emphasis on non-recurring transactional revenue. The company continues to focus its sales and marketing efforts on recurring subscription-based software services, and management expects that a portion of revenue may continue to be derived from non-recurring transactions, but the strategy remains focused on increasing recurring subscription revenue. Management highlights the increase in revenue primarily attributable to growth in recurring subscription revenue across the company's compliance, supply chain, and traceability solutions, driven by increased regulatory requirements, food safety and traceability initiatives, and greater demand for transparency throughout the food supply chain. The company's strategic priorities include expanding its traceability solutions, continuing to develop patent-pending technologies, and pursuing its investment and commercial relationship with SPAR Group, Inc. Management also emphasizes the company's commitment to returning capital to shareholders through quarterly cash dividends and share repurchases, as well as redeeming the remaining outstanding Preferred Stock on or before December 31, 2026, subject to the availability of sufficient cash and other applicable considerations.

Total revenue for the fiscal year ended June 30, 2026 was $23,287,319 ⁵, compared to $22,606,066 ⁶ for the fiscal year ended June 30, 2025. Net income was $7,569,487 ⁷ for fiscal 2026, compared to $6,978,127 ⁸ for fiscal 2025. Basic and diluted earnings per share were $0.41 ⁹ and $0.41 ¹⁰ for fiscal 2026, respectively, compared to $0.38 ¹¹ and $0.38 ¹² for fiscal 2025. Cost of services and product support was $3,306,855 ¹³, or 14% ¹⁴ of total revenue, for fiscal 2026, compared with $3,681,330 ¹⁵, or 16% ¹⁶ of total revenue, for fiscal 2025. Sales and marketing expense was $5,751,151 ¹⁷, or 25% ¹⁸ of total revenue, for fiscal 2026, compared with $5,843,272 ¹⁹, or 26% ²⁰ of total revenue, for fiscal 2025. General and administrative expense was $5,738,314 ²¹, or 25% ²² of total revenue, for fiscal 2026, compared with $5,602,807 ²³, or 25% ²⁴ of total revenue, for fiscal 2025. Depreciation and amortization expense was $647,637 ²⁵ for fiscal 2026, compared with $1,251,514 ²⁶ for fiscal 2025. Net other income was $1,676,124 ²⁷ for fiscal 2026, compared with $1,426,834 ²⁸ for fiscal 2025. Preferred dividends were $167,804 ²⁹ for fiscal 2026, compared with $360,306 ³⁰ for fiscal 2025. Cash and cash equivalents were $27,256,008 ³¹ as of June 30, 2026, compared with $28,568,805 ³² as of June 30, 2025. Net cash provided by operating activities was $8,224,806 ³³ for fiscal 2026, compared with $8,420,132 ³⁴ for fiscal 2025. Net cash used in investing activities was $4,117,006 ³⁵ for fiscal 2026, compared with nominal net cash provided by investing activities of $169 ³⁶ in fiscal 2025. Net cash used in financing activities was $5,420,597 ³⁷ for fiscal 2026, compared with $5,005,358 ³⁸ for fiscal 2025. Working capital was $24.2 million ³⁹ at June 30, 2026, compared with $28.2 million ⁴⁰ at June 30, 2025. Current assets totaled $32,752,828 ⁴¹ as of June 30, 2026, compared to $33,685,800 ⁴² as of June 30, 2025. Current liabilities were $8,505,379 ⁴³ as of June 30, 2026, compared with $5,531,118 ⁴⁴ as of June 30, 2025. The current ratio was 3.85 ⁴⁵ as of June 30, 2026, compared with 6.09 ⁴⁶ as of June 30, 2025. The company had no outstanding bank debt and no borrowing availability under the former credit facility as of June 30, 2026. Total contractual obligations for financing leases were $294,340 ⁴⁷ as of June 30, 2026, with lease payments of $305,591 ⁴⁸ and imputed interest of $11,251 ⁴⁹. The company's revenue is primarily derived from subscription and support services, with subscription and support revenue of $22,606,066 ⁵⁰ in fiscal 2025 and professional services revenue of $1,426,834 ⁵¹ in fiscal 2025, though the filing does not provide a full segment breakdown for fiscal 2026.

The company's business is dependent upon the continued services of its founder and Chief Executive Officer, Randall K. Fields, and the loss of his services may have a materially adverse effect upon the business. The company's investment in SPAR Group, Inc. is subject to risks associated with an equity investment in a publicly traded company, including fluctuations in the market price and liquidity of SPAR's common stock, and as of June 30, 2026, the company beneficially owned approximately 14.8% ¹ of SPAR's outstanding common stock, increasing to approximately 31% ² after the July 1, 2026 acquisition. The company's obligation to make principal and interest payments under the Note issued in connection with the SPAR investment is independent of the performance or value of the investment, and required payments will reduce cash otherwise available for operations, investments, acquisitions, dividends, share repurchases, or other corporate purposes. A delay in the deadline for compliance with FSMA 204, which was extended by 30 months to July 20, 2028, may slow the adoption of the company's technology as a compliance tool, negatively affecting revenue. The company faces risks related to the sale and delivery of merchandise to customers, including dependence on other companies to perform functions critical to delivering products, and in limited circumstances, the company sells merchandise it has purchased, assuming risks related to inventory. The company's officers and directors control approximately 37% ³ of the company's Common Stock, and Randall K. Fields controls 31% ⁴, which could lead to conflicts with other stockholders over corporate governance.